Rigel Pharmaceuticals Inc
RIGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001034842
No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Rigel Pharmaceuticals Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 125 | 118 | −7 |
| Shares | 112.4M | 110.6M | −1.79M (−1.6%) |
| Value | $148.6M | $142.7M | −$5.89M (−4.0%) |
New holders (6)
Institutions that held Rigel Pharmaceuticals Inc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Natixis | 57,246 | $73.8K | 0.00% |
| Virtu Financial LLC | 50,288 | $65.0K | 0.00% |
| Vontobel Holding Ltd. | 30,000 | $38.7K | 0.00% |
| Squarepoint Ops LLC | 19,929 | $25.7K | 0.00% |
| Alpine Global Management, LLC | 12,868 | $16.6K | 0.00% |
| Schonfeld Strategic Advisors LLC | 12,000 | $15.5K | 0.00% |
Sold out (13)
Institutions that held Rigel Pharmaceuticals Inc at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 1,822,376 | $2.41M |
| Marshall Wace, LLP | 172,731 | $228.0K |
| Hussman Strategic Advisors, Inc. | 156,000 | $205.9K |
| Panagora Asset Management Inc | 151,316 | $199.7K |
| SG Americas Securities, LLC | 149,771 | $198.0K |
| Man Group plc | – | $189.2K |
| Lazard Asset Management LLC | 39,840 | $52.0K |
| Two Sigma Securities, LLC | 28,811 | $38.0K |
| HighTower Advisors, LLC | 17,154 | $22.0K |
| Advisory Services Network, LLC | 2,000 | $2.64K |
| Ten Capital Wealth Advisors, LLC | 2,000 | $2.64K |
| Point72 Asset Management, L.P. | 751 | $991 |
| International Assets Investment Management, LLC | 71 | $94 |